Search datasets
-
The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) study is a multinational, double-blind, randomized, placebo controlled trial which was recently published....
Search relevance: 1.00 | Views last month: 4 | Catalog Last Checked: July 31, 2026 at 08:59 PM